The evolution of pharma social media intelligence

Is your company a fully mature user of intelligence from social media, or is it still not tapping into insights? As shown in the consumer world, social media can be a very rich source of insights into customers and markets, and can provide early signals of new trends. Exactly the same is true for patient and health care provider insights, especially when used with other more traditional data sets. But understanding how to engage, and how to extract the right data to get actionable insights – and all the while complying with regulations – isn’t so straightforward. Life sciences companies in particular, want to put this new data source in context with its already broad range of metrics. Achieving this calls for a step-by-step progression towards social media maturity. pharmaphorum is working in collaboration with experts from IQVIA and Professor Andrew Stephen of Oxford University to deliver a topical debate focussed on this field, intended to provide answers to some of the conundrums the industry faces. An expert panel will provide practical advice and real-life examples of how pharmaceutical companies can develop maturity in social media intelligence. Increase your understanding of how social media can easily be used to ultimately add value Learn the tricks - how, when and why marketers from other sectors use social media channels to their advantage Hear how leading pharma organisations have embraced social media and have seen real results